Table I summarizes the OOS investigational components that have overlap between the two major branches of the investigation.> While these points are identified as overlaps between the "Analytical" and "Dose Formulations" sections, it is important to remember that other areas of overlap might also exist and should be considered, regardless of the stage of the investigation.
The use of an additional chemotherapy component remains investigational.
Accordingly, DGJ is the active component of an investigational new drug, migalastat hydrochloride (AT1001, GR181413A), that currently is in clinical development to evaluate its safety and efficacy as a potential treatment for Fabry disease [Schiffmann et al., 2008].
It is a key component in a number of investigational vaccine formulations addressing a variety of indications, including infectious diseases, cancers and degenerative disorders.
In multivariate analyses, regular disclosure of study product use and partner approval for the diaphragm and gel were significantly associated with women's acceptability and consistent use of the products; an essential component for determining efficacy of investigational prevention methods.
69 Currently most investigators regard combination therapy as investigational.
Women's report of full disclosure of study product use and partner approval for products were significantly associated with their acceptability and consistent use; an essential component of determining the efficacy of an investigational prevention method.
Patients who were at imminent risk of injuring themselves or others or of causing significant damage to property, who were hypersensitive to RLAT or any of its components, or who had been treated with investigational agents within the previous 30 days were not eligible for enrollment.
Patients who were at imminent risk of injury to themselves or others or of causing significant damage to property, who had a known hypersensitivity to RLAT or any of its components, or who had been treated with investigational agents within the previous 30 days were not eligible for enrollment.
Addition of each vaccine component to the DTP-HB-Hib combination kept safety profile of the investigational DTP-HB-Hib combination vaccine appeared to be similar to that of the DTP-HB-based combination vaccine and licensed-equivalent vaccines.
